UPDATE : Tuesday, January 16, 2018
상단여백
People with experiences more positive about clinical trials
People who have experienced clinical trials for medicines have a more posit...
by Lee Hye-seon  |  2017-07-07 16:41
라인
Breast cancer therapy Ibrance likely to get insurance benefit
Pfizer’s breast cancer therapy Palbociclib, better known as Ibrance, is lik...
by Nam Doo-hyun  |  2017-07-07 14:26
라인
Bristol-Myers Squibb’s anti-arthritis drug wins FDA approval
Bristol-Myers Squibb said Thursday the U.S. Food and Drug Administration ha...
by Marian Chu  |  2017-07-07 09:59
라인
Korea’s medical supplies market grew to $17.3 billion last year
The nation’s market of medicine and medical supplies increased 12.9 percent...
by Marian Chu  |  2017-07-06 16:49
라인
Will patent lawsuit results affect market of Lyrica Capsule?
Pfizer partially won a legal battle over Lyrica Cap. with 13 Korean pharmac...
by Lee Hye-seon  |  2017-07-06 15:04
라인
Korea one of the first countries to issue warnings on finasteride
Korea has become one of the first countries to warn the public of the depre...
by Marian Chu  |  2017-07-05 18:22
라인
Boryung, Kiara sign contract for high blood pressure drug
Boryung Pharmaceuticals said Tuesday it had signed a memorandum of understa...
by Constance Williams  |  2017-07-05 17:15
라인
LG Chem’s antidiabetic hits monthly sale of $5.2 million in May
LG Chem’s diabetes drug Zemiglo has hit a sales milestone of 6 billion won ...
by Marian Chu  |  2017-07-05 10:40
라인
YuYu’s osteoporosis treatment shows fracture-preventing effects
YuYu Pharma’s treatment for osteoporosis, Maxmarvil, can help to prevent os...
by Constance Williams  |  2017-07-05 10:39
라인
Samsung BioLogics signs $55-million contract with India’s Sun Pharma
Samsung BioLogics and Sun Pharma of India have signed a contract for the pr...
by Constance Williams  |  2017-07-04 16:36
라인
Roche Korea’s anticancer drug wins FDA approval
Roche Korea said Monday that its anti-PD-L1 immunotherapy anticancer drug T...
by Constance Williams  |  2017-07-04 12:30
라인
Ministry adds warnings to hair growth solution
The Ministry of Food and Drug Safety announced plans Tuesday to revise warn...
by Marian Chu  |  2017-07-04 11:24
라인
Insurance benefit expands for Pfizer’s anti-arthritis therapy
Korea Pfizer Pharmaceutical (CEO Oh Dong-wook) said Monday the health insur...
by Constance Williams  |  2017-07-04 10:24
라인
Antipyretic Fiblast makes 4th attempt to get insurance benefits
Fiblast, a cell therapy product to treat burn injuries, will make its fourt...
by Lee Hye-seon  |  2017-07-03 17:15
라인
Regulators exclude Dong-A ST drug’s gastritis-preventing function from insurance benefits
Beginning this month, Dong-A ST will not be able to receive insurance benef...
by Lee Hye-seon  |  2017-07-03 16:10
라인
‘Orphan’ drugs emerge as new targets of pharmaceuticals
Pharmaceutical companies have been increasingly developing drugs for rare d...
by Marian Chu  |  2017-07-03 16:01
라인
Shire Korea improves its hemophilia B treatment
Shire Korea has improved the function of its Hemophilia B treatment, Rixubi...
by Constance Williams  |  2017-07-03 14:07
라인
Health industry export exceeds $10 billion for 1st time last year
Korea’s export of medicines and medical equipment exceeded $10 billion for ...
by Kwak Sung-sun  |  2017-06-30 14:11
라인
Hepatitis C treatment data presented at ‘Liver Week 2017’
Korea BMS Pharma (CEO: Park Hye-sun) presented their research of genotype 1...
by Constance Williams  |  2017-06-30 10:51
라인
Celltrion applies for FDA approval of anticancer biosimilar
The U.S. Food and Drug Administration (FDA) has accepted Celltrion’s applic...
by Constance Williams  |  2017-06-29 18:03
여백
여백
여백
Back to Top